American Medical Services offers pharmacogenetics testing to provide insight as to a patient’s likeliness to experience an adverse reaction or a non-response to a drug. Elite’s pharmacogenetics testing includes 25 genes targeting more than 70 genetic variants that are especially dedicated to drug therapy in pain management, psychological disorders and cardiovascular diseases. This testing utilizes one of the most advanced instruments designed for gene detection.
With its optimized automation and high-throughput capability, American Medical Services is able to offer an advanced pharmacogenetics testing highlighting every individual’s specific genetic makeup that predetermines drug metabolism or lack thereof. This insight not only helps healthcare providers determine which class of medication to prescribe but also identifies any adverse reactions to medication classes that could possibly occur.